Hager Biosciences
Biotechnology, 116 Research Dr, BETHLEHEM, Pennsylvania, 18015, United States, 1-10 Employees
Phone Number: 61********
Who is HAGER BIOSCIENCES
Hager Biosciences, LLC is a preclinical-stage drug discovery organization practicing innovative discovery medicinal chemistry. Hager's main mission is to become a preferred partner to pha...
Read More
-
Headquarters: 116 Research Dr, BETHLEHEM, Pennsylvania, 18015, United States
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from HAGER BIOSCIENCES
Hager Biosciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Hager Biosciences
Answer: Hager Biosciences's headquarters are located at 116 Research Dr, BETHLEHEM, Pennsylvania, 18015, United States
Answer: Hager Biosciences's phone number is 61********
Answer: Hager Biosciences's official website is https://hagerbio.com
Answer: Hager Biosciences's revenue is $1 Million to $5 Million
Answer: Hager Biosciences's SIC: 8731
Answer: Hager Biosciences has 1-10 employees
Answer: Hager Biosciences is in Biotechnology
Answer: Hager Biosciences contact info: Phone number: 61******** Website: https://hagerbio.com
Answer: Hager Biosciences, LLC is a preclinical-stage drug discovery organization practicing innovative discovery medicinal chemistry. Hager's main mission is to become a preferred partner to pharmaceutical and biotech firms by providing therapeutic leads through out-licensing for unmet medical needs. Central to the business model is Hager's capability to design and synthesize proprietary small fragment molecules for modular adaptation into new or existing drug candidate optimization or novelization projects. Hager's discovery FragPhore platform provides a competitive and efficient advantage for rapid novel lead generation, optimization and drug rescue via profile/properties improvement, as well as modular fragments swap for intellectual property enhancement. Hagers highly cost-effective and efficient discovery research process including using outsourced network infrastructures has a solid track records of innovative preclinical pharmaceutical candidate discovery in CNS therapeutic spaces attested by several IP estates generated. Recent examples of awarded patents as well as filed patent applications from which two clinical candidates are on the verge of entering human clinical trials for Alzheimer diseases include: 11,505,555 10,329,301 11,414,425 10,815,242 11,142,529 11,312,721 16/445,854 63/399,509 WO2020247447 WO2020247445 US2022/0259224 63/403,019 63/400,894
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month